Figure 3.
Impact of intended and relative dose intensity of R-CHOP in patients ≥ 70 years with DLBCL in a representative, consecutive cohort across 8 UK centers (2009-2018) treated with curative intent. (A) OS and (B) PFS by age and intended dose intensity. Reprinted from Eyre24 with permission of the Journal of Internal Medicine.